LANGaware, a NYC-based AI-driven healthcare technology company, raised $2M in funding.
The round was led by Eleven Ventures, with participation from Metavallon VC.
The company intends to use the funds to enhance its technology and product teams, expand its business development efforts, and extend its presence across virtual care platforms and health systems in the United States.
Founded by Dr. Vassiliki Rentoumi, LANGaware uses AI to predict and monitor cognitive and mental health conditions such as Mild Cognitive Decline, Alzheimer’s Disease, and Depression. By utilizing speech analysis and proprietary voice and speech biomarkers, the company surfaces early and objective detection of conditions, enabling effective treatments, reducing healthcare burdens, and improving overall well-being. Developed over several years of research, the platform has been tested and proven effective in both clinical and virtual care settings in the US and Greece – improving patient outcomes and reducing healthcare costs. LANGaware aids health systems, providers, and pharma firms by facilitating early detection and tailored support for those at risk or impacted by neurodegenerative and psychiatric disorders, ensuring accurate diagnoses, minimizing misdiagnosis, and unnecessary treatments.
FinSMEs
04/10/2023